BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5748255)

  • 21. [The significance of the renal vessels for the course of chronic pyelonephritis and calculus nephrosis].
    HOLLE G
    Virchows Arch Pathol Anat Physiol Klin Med; 1959; 332():494-507. PubMed ID: 14402649
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diagnostic value of tear analysis in uremia, uricemia and cholesterolemia].
    Terekhina NA; Petrovich IuA
    Klin Lab Diagn; 1994; (6):17-8. PubMed ID: 7894898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostic problems in chronic uremia (polycentric studies)].
    Piccoli G; Alloatti S; Segoloni G; Triolo G; Petrella E; Scatolini G; Miletti M; Castellani A; Biagini M; Bartolomeo F; Labate C; Petrarulo F; Passavanti G
    Minerva Nefrol; 1976; 23(1):25-9. PubMed ID: 995328
    [No Abstract]   [Full Text] [Related]  

  • 24. [Features of uric acid metabolism in leukemia].
    Poddubnaia IV
    Sov Med; 1970 Jul; 33(7):57-64. PubMed ID: 4923187
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hyperuricemia].
    Harlay A
    Infirm Fr; 1984 Dec; (260):11-2. PubMed ID: 6570463
    [No Abstract]   [Full Text] [Related]  

  • 26. [Incidence of metabolic disorders in patients with recurrent urinary calculi].
    Schröder HE; Lohse R; Böhm WD
    Z Urol Nephrol; 1981 Mar; 74(3):235-41. PubMed ID: 7223105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinico-metabolic effects induced by the administration of concentrated liver extract in chronic uremia].
    Mioli V; Albertazzi A; Vangelista A
    Minerva Med; 1968 Sep; 59(75):3931-8. PubMed ID: 5684815
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hyperuricemia and gout].
    Oehler G; Lasch HG
    Med Welt; 1980 Apr; 31(16):575-81. PubMed ID: 7392922
    [No Abstract]   [Full Text] [Related]  

  • 29. [On non-protein nitrogen and carbamid nitrogen tests for the characterization of azotemia].
    Sajfos L; Pelle J
    Orv Hetil; 1968 Oct; 109(43):2390-1. PubMed ID: 5720083
    [No Abstract]   [Full Text] [Related]  

  • 30. Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia.
    Lin KC; Tsao HM; Chen CH; Chou P
    J Rheumatol; 2004 Jun; 31(6):1152-8. PubMed ID: 15170929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [On the method of enterorevascularization of the kidney in chronic pyelonephritis].
    Khomenko VF; Modorskiĭ MI
    Vestn Khir Im I I Grek; 1966 Sep; 97(9):85-6. PubMed ID: 6000841
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hyperuricemia and plasma renin activity in essential arterial hypertension].
    Milicević Z; Jelaković B; Marinković M
    Lijec Vjesn; 1994; 116(1-2):14-7. PubMed ID: 8028431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary calculi, obstructive nephropathy and unexpected death.
    Byard RW
    Forensic Sci Med Pathol; 2011 Sep; 7(3):301-3. PubMed ID: 20886314
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical manifestations of patients with hyperuricemia.
    Akkasilpa S; Avihingsanon Y; Hanvivadhanakul P; Wonchinsri J
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S41-4. PubMed ID: 16083159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local factors compared with systemic factors in the formation of bladder uric acid stones.
    Li WM; Chou YH; Li CC; Liu CC; Huang SP; Wu WJ; Huang CH
    Urol Int; 2009; 82(1):48-52. PubMed ID: 19172097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic difficulties in the course of renal complications of gout].
    Kossakowski D; Sidorski S
    Reumatologia; 1966; 4(4):357-62. PubMed ID: 5961003
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum uric acid: a risk factor and a target for treatment?
    Feig DI; Mazzali M; Kang DH; Nakagawa T; Price K; Kannelis J; Johnson RJ
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S69-73. PubMed ID: 16565251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Attempt at normalizing the uricemia in gout].
    Piliaev VG
    Vrach Delo; 1980 Apr; (4):88-90. PubMed ID: 7385782
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Deposition of crystalline uric acid in the kidneys].
    Emmrich P
    Zentralbl Allg Pathol; 1966; 109(5):507-11. PubMed ID: 5300163
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.